Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

Inno8, the first orally administered factor VIII mimetic shows favorable safety, pharmacokinetic, and pharmacodynamic properties in healthy male participants

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Blood Disorders
Congress oral presentation
Inno8